Parker-Hannifin Corporation — Form 10-Q Summary
Reporting period: Fiscal first quarter ended September 30, 2021; unaudited results compared with the three months ended September 30, 2020. Amounts are in U.S. dollars unless stated otherwise. The prior period was adjusted for a change in inventory accounting.
Business context and results
Parker-Hannifin is a global motion- and control-technology company operating through Diversified Industrial and Aerospace Systems. First-quarter sales increased primarily on higher volume in both segments. Management cited recovery in commercial aerospace alongside continued supply-chain and labor-market disruption.
| Metric | Q1 FY2022 | Q1 FY2021 |
|---|---|---|
| Net sales | $3.763 billion | $3.231 billion |
| Gross margin | 27.9% | 26.1% |
| Income before taxes | $571.7 million | $413.2 million |
| Net income attributable to common shareholders | $451.2 million | $319.8 million |
| Diluted EPS | $3.45 | $2.45 |
| Operating cash flow | $424.4 million | $737.4 million |
| Capital expenditures | $48.2 million | $42.1 million |
Sales rose approximately 16.5% year over year and attributable net income approximately 41%. Higher volume, continuous-improvement benefits and price increases supported margins; higher freight, material and labor costs and production inefficiencies partly offset those benefits. SG&A included $13 million of Meggitt transaction costs. Other expense included $39 million of acquisition-related financing fees.
Segments and backlog
| Segment | Sales, Q1 FY2022 | Sales, Q1 FY2021 | Operating margin, Q1 FY2022 | Backlog at Sept. 30, 2021 |
|---|---|---|---|---|
| Diversified Industrial | $3.170 billion | $2.657 billion | North America 18.6%; International 21.2% | $3.583 billion |
| Aerospace Systems | $592.7 million | $573.2 million | 20.0% | $3.200 billion |
Diversified Industrial sales growth reflected higher demand across many markets, with oil and gas among the areas of weakness. Aerospace sales increased on higher commercial OEM and aftermarket volume, partly offset by lower military volume. Company backlog was $6.783 billion; approximately 85% was expected to be recognized as revenue within 12 months.
Liquidity, debt and capital allocation
At September 30, 2021, cash and cash equivalents were $478.6 million, with another $40.2 million in marketable securities and other investments. The company also held $215 million of restricted cash in an acquisition escrow account. Total current assets were $5.631 billion and current liabilities $3.283 billion. Balance-sheet debt was approximately $6.566 billion, including $302.3 million current and $6.264 billion long-term. The debt-to-debt-plus-equity ratio was 0.44 versus a 0.65 covenant limit; the company reported covenant compliance and $3.0 billion available under its revolving credit agreement at quarter end.
Operating cash flow fell by $313 million year over year, mainly because working-capital requirements increased by $362 million, partly offset by higher net income. Inventory rose to $2.265 billion from $2.091 billion at June 30; days of inventory supply were 86, compared with 75 at June 30. Financing cash outflow included $230 million of share repurchases and $133 million of dividends. The company repurchased 767,600 shares at an average $300.07 per share and paid a $1.03-per-share dividend.
Outlook, transactions and risks
- Management expected a fiscal 2022 effective tax rate of approximately 23%. It targeted capital expenditures at 2% of sales; no specific consolidated sales or earnings forecast is provided in the filing.
- The company anticipated approximately $37 million of additional Diversified Industrial business-realignment and acquisition-integration charges during the remainder of fiscal 2022. It did not expect significant additional Aerospace Systems realignment or integration charges during that period.
- The proposed cash acquisition of Meggitt was valued at approximately £6.255 billion at September 30 and remained subject to customary closing conditions, including regulatory clearances. At quarter end, the related bridge financing commitment was £5.1 billion and a $2.0 billion delayed-draw term loan facility was available for acquisition funding. In October, the company issued $2.126 billion of commercial paper, added funds to the escrow account, entered into £6.415 billion of deal-contingent currency forwards, and reduced the bridge commitment to £3.2 billion.
- Management identified continuing uncertainty from COVID-19 and its residual effects, global supply-chain and labor constraints, inflationary input costs, and aerospace-market conditions. Other stated risks include acquisition completion and integration, customer or supplier disruptions, leverage and debt service, foreign exchange, regulatory approvals, and legal and tax matters.
- Gross unrecognized tax benefits were $99 million, with $18 million of accrued interest; up to approximately $40 million could be reduced within 12 months. The filing also notes environmental proceedings generally, without specifying a material case or quantified exposure in the provided text.
Most important facts for investors to verify
- Whether sales growth and margin improvement persist as supply, labor, freight and materials pressures evolve.
- Whether working-capital investment—particularly inventory—converts into cash flow and whether operating cash generation recovers.
- Meggitt acquisition approval, timing, final funding mix, currency-hedge settlement and the resulting debt burden.
- Delivery of backlog into revenue, especially in aerospace, and the strength of commercial and military demand.
- Actual restructuring and integration costs, tax-rate outcomes, and compliance with debt covenants and liquidity commitments.